Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

232 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serum creatinine on admission predicts long-term mortality in acute myocardial infarction patients undergoing successful primary angioplasty: data from the Heart Institute of Japan Acute Myocardial Infarction (HIJAMI) Registry.
Yamaguchi J, Kasanuki H, Ishii Y, Yagi M, Nagashima M, Fujii S, Koyanagi R, Ogawa H, Hagiwara N, Haze K, Sumiyoshi T, Honda T; HIJC Investigators. Yamaguchi J, et al. Among authors: haze k. Circ J. 2007 Sep;71(9):1354-9. doi: 10.1253/circj.71.1354. Circ J. 2007. PMID: 17721010 Free article.
Nifedipine retard prevents hospitalization for angina pectoris better than angiotensin-converting enzyme inhibitors in hypertensive Japanese patients with previous myocardial infarction (JMIC-B substudy).
Yui Y, Shinoda E, Kodama K, Hirayama A, Nonogi H, Haze K, Sumiyoshi T, Hosoda S, Kawai C; Japan Multicenter Investigation for Cardiovascular Diseases B (JMIC-B) Study Group. Yui Y, et al. Among authors: haze k. J Hypertens. 2007 Oct;25(10):2019-26. doi: 10.1097/HJH.0b013e32829c6908. J Hypertens. 2007. PMID: 17885543 Clinical Trial.
Effect of early statin treatment at standard doses on long-term clinical outcomes in patients with acute myocardial infarction (the Heart Institute of Japan, Department of Cardiology Statin Evaluation Program).
Nagashima M, Koyanagi R, Kasanuki H, Hagiwara N, Yamaguchi J, Atsuchi N, Honda T, Haze K, Sumiyoshi T, Urashima M, Ogawa H; Heart Institute of Japan, Department of Cardiology (HIJC) Investigators. Nagashima M, et al. Among authors: haze k. Am J Cardiol. 2007 Jun 1;99(11):1523-8. doi: 10.1016/j.amjcard.2007.01.024. Epub 2007 Apr 16. Am J Cardiol. 2007. PMID: 17531574
Reverse remodeling and improved function by antihypertensive treatment in hypertensive patients with coronary artery disease.
Yui Y, Kodama K, Hirayama A, Nishio R, Iwanaga Y, Nonogi H, Haze K, Sumiyoshi T, Yui N, Hosoda S, Kawai C; Japan Multicenter Investigation for Cardiovascular Diseases B (JMIC-B) Study Group. Yui Y, et al. Among authors: haze k. J Hypertens. 2010 Jan;28(1):178-85. doi: 10.1097/HJH.0b013e3283324668. J Hypertens. 2010. PMID: 19927011 Clinical Trial.
Quantitative coronary angiogram analysis: nifedipine retard versus angiotensin-converting enzyme inhibitors (JMIC-B side arm study).
Shinoda E, Yui Y, Kodama K, Hirayama A, Nonogi H, Haze K, Sumiyoshi T, Hosoda S, Kawai C; Japan Multicenter Investigation for Cardiovascular Diseases-B Study Group. Shinoda E, et al. Among authors: haze k. Hypertension. 2005 Jun;45(6):1153-8. doi: 10.1161/01.HYP.0000165677.71421.8c. Epub 2005 Apr 25. Hypertension. 2005. PMID: 15851624
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome.
Kimura K, Kimura T, Ishihara M, Nakagawa Y, Nakao K, Miyauchi K, Sakamoto T, Tsujita K, Hagiwara N, Miyazaki S, Ako J, Arai H, Ishii H, Origuchi H, Shimizu W, Takemura H, Tahara Y, Morino Y, Iino K, Itoh T, Iwanaga Y, Uchida K, Endo H, Kongoji K, Sakamoto K, Shiomi H, Shimohama T, Suzuki A, Takahashi J, Takeuchi I, Tanaka A, Tamura T, Nakashima T, Noguchi T, Fukamachi D, Mizuno T, Yamaguchi J, Yodogawa K, Kosuge M, Kohsaka S, Yoshino H, Yasuda S, Shimokawa H, Hirayama A, Akasaka T, Haze K, Ogawa H, Tsutsui H, Yamazaki T; Japanese Circulation Society Joint Working Group. Kimura K, et al. Among authors: haze k. Circ J. 2019 Apr 25;83(5):1085-1196. doi: 10.1253/circj.CJ-19-0133. Epub 2019 Mar 29. Circ J. 2019. PMID: 30930428 Free article. Review. No abstract available.
Angiotensin II receptor blocker-based vs. non-angiotensin II receptor blocker-based therapy in patients with angiographically documented coronary artery disease and hypertension: the Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease (HIJ-CREATE).
Kasanuki H, Hagiwara N, Hosoda S, Sumiyoshi T, Honda T, Haze K, Nagashima M, Yamaguchi J, Origasa H, Urashima M, Ogawa H; HIJ-CREATE Investigators. Kasanuki H, et al. Among authors: haze k. Eur Heart J. 2009 May;30(10):1203-12. doi: 10.1093/eurheartj/ehp101. Epub 2009 Apr 4. Eur Heart J. 2009. PMID: 19346521 Clinical Trial.
Angiotensin receptor blocker-based therapy and cardiovascular events in hypertensive patients with coronary artery disease and impaired renal function.
Shiga T, Kasanuki H, Hagiwara N, Sumiyoshi T, Honda T, Haze K, Takagi A, Kawana M, Origasa H, Ogawa H; Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease (Hij-Create) Investigators. Shiga T, et al. Among authors: haze k. Blood Press. 2010 Dec;19(6):359-65. doi: 10.3109/08037051003802475. Epub 2010 May 24. Blood Press. 2010. PMID: 20491606 Free article. Clinical Trial.
Elevated plasma levels of oxidized low-density lipoprotein relate to the presence of angiographically detected complex and thrombotic coronary artery lesion morphology in patients with unstable angina.
Yamashita H, Ehara S, Yoshiyama M, Naruko T, Haze K, Shirai N, Sugama Y, Ikura Y, Ohsawa M, Itabe H, Kataoka T, Kobayashi Y, Becker AE, Yoshikawa J, Ueda M. Yamashita H, et al. Among authors: haze k. Circ J. 2007 May;71(5):681-7. doi: 10.1253/circj.71.681. Circ J. 2007. PMID: 17456991 Free article.
232 results